Can resveratrol help to maintain metabolic health?

Proceedings of the Nutrition Society

Volumn 73, Issue 2, 2014, Pages 271-277

  Schrauwen, Patrick ^a   Timmers, Silvie ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Ageing; Human subjects; Metabolic health; Mitochondria; Resveratrol

Indexed keywords

RESVERATROL; SIRTUIN 1; ENZYME ACTIVATOR; STILBENE DERIVATIVE;

CELL ENERGY; CONFERENCE PAPER; ENERGY METABOLISM; EXERCISE; LIPID STORAGE; METABOLIC DISORDER; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; RODENT; ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; HUMAN; MITOCHONDRION; SKELETAL MUSCLE;

ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; ENZYME ACTIVATORS; EXERCISE; HUMANS; MITOCHONDRIA; MUSCLE, SKELETAL; SIRTUIN 1; STILBENES;

EID: 84898430249     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665113003856     Document Type: Conference Paper

References (61)

1. Schrauwen-Hinderling VB, Hesselink MK, Schrauwen P, et al. (2006) Intramyocellular lipid content in human skeletal muscle. Obesity (Silver Spring) 14, 357-367
2. Gastaldelli A & Basta G (2010) Ectopic fat and cardiovascular disease: What is the link? Nutr Metab Cardiovasc Dis 20, 481-490
3. Krssak M, Falk Petersen K, Dresner A, et al. (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: A 1H NMR spectroscopy study. Diabetologia 42, 113-116
4. Roden M, Price TB, Perseghin G, et al. (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97, 2859-2865
5. Pan DA, Lillioja S, Kriketos AD, et al. (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46, 983-989
6. Ferrannini E, Vichi S, Beck-Nielsen H, et al. (1996) Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45, 947-953
7. Petersen KF, Befroy D, Dufour S, et al. (2003) Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 300, 1140-1142
8. Wijsman CA, Rozing MP, Streefland TC, et al. (2011) Familial longevity is marked by enhanced insulin sensitivity. Aging Cell 10, 114-121
9. Wijsman CA, van Opstal AM, Kan HE, et al. (2012) Proton magnetic resonance spectroscopy shows lower intramyocellular lipid accumulation in middle-Aged subjects predisposed to familial longevity. Am J Physiol Endocrinol Metab 302, E344-E348
10. Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, et al. (2000) Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 49, 2102-2107
11. Mensink M, Blaak EE, van Baak MA, et al. (2001) Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50, 2548-2554
12. Simoneau JA, Veerkamp JH, Turcotte LP, et al. (1999) Markers of capacity to utilize fatty acids in human skeletal muscle: Relation to insulin resistance and obesity and effects of weight loss. FASEB J 13, 2051-2060
13. Simoneau JA & Kelley DE (1997) Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83, 166-171
14. Kelley DE, He J, Menshikova EV, et al. (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-2950
15. Mootha VK, Lindgren CM, Eriksson KF, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34, 267-273
16. Patti ME, Butte AJ, Crunkhorn S, et al. (2003) Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 100, 8466-8471
17. Schrauwen-Hinderling VB, Kooi ME, Hesselink MK, et al. (2007) Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 50, 113-120
18. Sahlin K, Harris RC & Hultman E (1979) Resynthesis of creatine phosphate in human muscle after exercise in relation to intramuscular pH and availability of oxygen. Scand J Clin Lab Invest 39, 551-558
19. Kemp GJ & Radda GK (1994) Quantitative interpretation of bioenergetic data from 31P and 1H magnetic resonance spectroscopic studies of skeletal muscle: An analytical review. Magn Reson Q 10, 43-63
20. Phielix E, Schrauwen-Hinderling VB, Mensink M, et al. (2008) Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 57, 2943-2949
21. Holloszy JO (2009) Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. Am J Clin Nutr 89, 463S-466S.
22. Hoeks J & Schrauwen P (2012) Muscle mitochondria and insulin resistance: A human perspective. Trends Endocrinol Metab 23, 444-450
23. Nielsen J, Mogensen M, Vind BF, et al. (2010) Increased subsarcolemmal lipids in type 2 diabetes: Effect of training on localization of lipids, mitochondria, and glycogen in sedentary human skeletal muscle. Am J Physiol Endocrinol Metab 298, E706-E713
24. Meex RC, Schrauwen-Hinderling VB, Moonen-Kornips E, et al. (2010) Restoration of muscle mitochondrial function and metabolic flexibility in type 2 diabetes by exercise training is paralleled by increased myocellular fat storage and improved insulin sensitivity. Diabetes 59, 572-579
25. Phielix E, Meex R, Moonen-Kornips E, et al. (2010) Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals. Diabetologia 53, 1714-1721
26. Hey-Mogensen M, Hojlund K, Vind BF, et al. (2010) Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes. Diabetologia 53, 1976-1985
27. Phielix E, Meex R, Ouwens DM, et al. (2012) High oxidative capacity due to chronic exercise training attenuates lipid-induced insulin resistance. Diabetes 61, 2472-2478
28. Heilbronn LK, de Jonge L, Frisard MI, et al. (2006) Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: A randomized controlled trial. J Am Med Assoc 295, 1539-1548
29. Larson-Meyer DE, Newcomer BR, Heilbronn LK, et al. (2008) Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) 16, 1355-1362
30. Civitarese AE, Carling S, Heilbronn LK, et al. (2007) Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med 4, e76
31. Yamamoto H, Schoonjans K & Auwerx J (2007) Sirtuin functions in health and disease. Mol Endocrinol 21, 1745-1755
32. Howitz KT, Bitterman KJ, Cohen HY, et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196
33. Canto C, Jiang LQ, Deshmukh AS, et al. (2010) Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 11, 213-219
34. Price NL, Gomes AP, Ling AJ, et al. (2012) SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15, 675-690
35. Takaoka M (1939) Resveratrol, a new phenolic compound from Veratrum grandiflorum. Nippon Kagaku Kaichi 60, 1090-1100 (in Japanese
36. Siemann EH & Creasy LL (1992) Concentration of the Phytoalexin resveratrol in wine. Am J Enol Viticult 43, 49-52
37. Baur JA & Sinclair DA (2006) Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Disc 5, 493-506
38. Vang O, Ahmad N, Baile CA, et al. (2011) What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS ONE 6, e19881
39. Baur JA, Pearson KJ, Price NL, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342
40. Lagouge M, Argmann C, Gerhart-Hines Z, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109-1122
41. Wood JG, Rogina B, Lavu S, et al. (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686-689
42. Agarwal B & Baur JA (2011) Resveratrol and life extension. Ann N Y Acad Sci 1215, 138-143
43. Bass TM, Weinkove D, Houthoofd K, et al. (2007) Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev 128, 546-552
44. Valenzano DR, Terzibasi E, Genade T, et al. (2006) Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 16, 296-300
45. Dal-Pan A, Blanc S & Aujard F (2010) Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity. BMC Physiol 10, 11
46. Dal-Pan A, Terrien J, Pifferi F, et al. (2011) Caloric restriction or resveratrol supplementation and ageing in a non-human primate: First-year outcome of the RESTRIKAL study in Microcebus murinus. Age (Dordr) 33, 15-31
47. Elliott PJ, Walpole SM, Morelli L, et al. (2009) Resveratrol/SRT501 sirtuin SIRT1 activator treatment of type 2 diabetes. Drugs Future 34, 291-295
48. Brasnyo P, Molnar GA, Mohas M, et al. (2011) Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 106, 383-389
49. Crandall JP, Oram V, Trandafirescu G, et al. (2012) Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 67, 1307-1312
50. Ghanim H, Sia CL, Abuaysheh S, et al. (2010) An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol. J Clin Endocrinol Metab 95, E1-E8
51. Timmers S, Konings E, Bilet L, et al. (2011) Calorie restriction-like effects of 30 days of Resveratrol (resVidaTM) supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14, 612-622
52. Poulsen MM, Vestergaard PF, Clasen BF, et al. (2012) High-dose resveratrol supplementation in obese men: An investigator-initiated, randomized, Placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62, 1186-1195
53. Yoshino J, Conte C, Fontana L, et al. (2012) Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab 16, 658-664
54. Timmers S, Hesselink MK & Schrauwen P (2013) Therapeutic potential of resveratrol in obesity and type 2 diabetes: New avenues for health benefits? Ann N Y Acad Sci 1290, 83-89
55. Goodpaster BH, He J, Watkins S, et al. (2001) Skeletal muscle lipid content and insulin resistance: Evidence for a paradox in endurance-Trained athletes. J Clin Endocrinol Metab 86, 5755-5761
56. Koves TR, Sparks LM, Kovalik JP, et al. (2013) PPARgamma coactivator-1alpha contributes to exerciseinduced regulation of intramuscular lipid droplet programming in mice and humans. J Lipid Res 54, 522-534
57. Lin J, Wu H, Tarr PT, et al. (2002) Transcriptional co-Activator PGC-1 alpha drives the formation of slow-Twitch muscle fibres. Nature 418, 797-801
58. Bosma M, Hesselink MK, Sparks LM, et al. (2012) Perilipin 2 improves insulin sensitivity in skeletal muscle despite elevated intramuscular lipid levels. Diabetes 61, 2679-2690
59. Bosma M, Sparks LM, Hooiveld GJ, et al. (2013) Overexpression of PLIN5 in skeletal muscle promotes oxidative gene expression and intramyocellular lipid content without compromising insulin sensitivity. Biochim Biophys Acta 1831, 844-852
60. Schenk S, & Horowitz JF (2007) Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J Clin Invest 117, 1690-1698
61. Gliemann L, Schmidt JF, Olesen J, et al. (2013) Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men. J Physiol 591, 5047-5059